Vienna, Austria

ESTRO 2023

Session Item

Sunday
May 14
16:45 - 17:45
Business Suite 1-2
CNS
Anca-L. Grosu, Germany
2630
Poster Discussion
Clinical
Target volume delineation for radiotherapy of meningiomas: an ANOCEF consensus guideline.
Nicolas MARTZ, France
PD-0653

Abstract

Target volume delineation for radiotherapy of meningiomas: an ANOCEF consensus guideline.
Authors:

Nicolas MARTZ1, Julia Salleron2, Frédéric Dhermain3, Guillaume Vogin4, Jean-François Daisne5, Raphaelle Mouttet-Audouard6, Ronan Tanguy7, Georges Noel8, Matthieu Peyre9, Isabelle Lecouillard10, Julian Jacob11, Justine Attal12, Marie Charissoux13, Ovidiu Veresezan14, Chantal Hanzen14, Aymeri Huchet15, Igor Latorzeff16, Alexandre Coutte17, Jérôme Doyen18, Dinu Stefan19, Loic Feuvret11, Gabriel CTE Garcia20, Philippe Royer1

1Institut de Cancérologie de Lorraine, Radiotherapy, Vandoeuvre-Les-Nancy, France; 2Institut de Cancérologie de Lorraine, Cellule Data-biostatistique, Vandoeuvre-Les-Nancy, France; 3Gustave Roussy University Hospital, Radiotherapy, Villejuif, France; 4Centre Francois Baclesse, Radiotherapy, Luxembourg, Luxembourg; 5Leuven Cancer Institute, Radiotherapy, Leuven, Belgium; 6Oscar Lambret Comprehensive Cancer Centre, Radiotherapy, Lille, France; 7Léon Bérard Cancer Centre, Radiotherapy, Lyon, France; 8Paul Strauss Cancer Centre, Radiotherapy, Strasbourg, France; 9Groupe Hospitalier Pitié-Salpêtrière, Neurosurgery, Paris, France; 10Eugène Marquis Cancer Centre, Radiotherapy, Rennes, France; 11Hôpital Pitié-Salpêtrière Charles Foix, Radiotherapy, Paris, France; 12Institut Claudius Regaud, Radiotherapy, Toulouse, France; 13Centre Val d’Aurelle, Radiotherapy, Montpellier, France; 14Cancer Centre Henri Becquerel, Radiotherapy, Rouen, France; 15Centre Hospitalier et Universitaire de Bordeaux, Radiotherapy, Bordeaux, France; 16Groupe ONCORAD Garonne and Clinique Pasteur, Radiotherapy, Toulouse, France; 17Centre Hospitalier Universitaire d’Amiens, Radiotherapy, Amiens, France; 18Antoine Lacassagne Cancer Center, Radiotherapy, Nice, France; 19François Baclesse Cancer Centre, Radiotherapy, Rennes, France; 20Gustave Roussy University Hospital, Diagnostic Radiology, Villejuif, France

Show Affiliations
Purpose or Objective

Meningiomas are the most common primary intracranial tumor. They are developed at the expense of the arachnoid, with an overall incidence which has increased over the past decade. To date, there is no published specific guideline about meningiomas target volume. No prospective study has defined a consensus for delineation in meningiomas’ radiotherapy. Therefore, target volume definition is mainly based on retrospective studies, with a heterogeneous population of patients. The aim of this paper is to describe delineation guidelines for meningiomas’ radiotherapy as an adjuvant or definitive treatment with Intensity Modulated Radiation Therapy (IMRT) and stereotactic radiation therapy (SRT) techniques.

Material and Methods

This guideline is based on a consensus endorsed by a global multidisciplinary group of brain tumor experts’ member of the ANOCEF (French neuro-oncology association). A two round modified Delphi consensus was achieved, and the consensus was adopted by the RAND/UCLA method. The third round was carried out in videoconference, in order to allow experts to debate and argue on remaining uncertain proposals.

Results

Twenty experts from 17 radiotherapy center participated. After 3 rounds, all the proposals resulted in a consensus.


The ANOCEF guideline committee proposed to perform an unenhanced planning CT scan, merged with a post-contrast MRI obtained at the time of radiotherapy and preoperative MRI in case of adjuvant treatment.

GTV is defined by T1 contrast-enhancing lesion, thickened meninges, and directly invaded bone.

For IMRT, the CTV include:
- Grade I: No margin around the GTV.
Grade II: Margin of 5 mm to expand GTV in normal brain tissue, hyperostosis, along the unthickened meninges and venous sinuses if the GTV is coming into contact.
Grade III: Margin of 10 mm to expand GTV in normal brain tissue, hyperostosis, along the unthickened meninges, and optic or cranial nerves in contact with GTV.

In case of bone invasion, a margin of 5 or 10 mm in the healthy bone around the GTV is recommended, for grade II or III respectively. Otherwise, it is considered as an anatomical barrier and does not need to be included in the target volume.

In case of post-operative radiotherapy, no additional margin is required for CTV for grade I around tumor bed. A 5 and 10 mm margin is required for grade II and III. The cranial flap should only be included in the CTV only over 5 or 10 mm for grades II or III, in case of initially invaded bone. The drill holes and osteotomy areas should be included if they come into contact with target volume.

SRT is not recommended for grades II and III, excluding relapse situation. CTV corresponds to GTV without additional margin.

Conclusion

The current consensus provides a detailed delineation guideline for meningioma, suggesting smaller margins than the major studies published to date.